China Oncology

Loading...

Welcome to China Oncology,

China Oncology

30 May 2023, Volume 33 Issue 5 Previous Issue Next Issue

Contents of Issue 5, 2023

2023, 33 (5): 2-2.

Abstract ( 65) PDF (10595KB) ( 194 )

Specialists' Commentary

Advances in basic research, clinical diagnosis and treatment of thyroid cancer in 2022

QU Ning, WANG Yuting, MA Ben, WANG Yu

2023, 33 (5): 423-430. doi: 10.19401/j.cnki.1007-3639.2023.05.001

Abstract ( 408) PDF (1107KB) ( 1219 ) HTML ( 61 )

The value of surgery in the patients with de novo stage Ⅳ breast cancer

CHEN Luyan, WANG Lixue, FU Peifen

2023, 33 (5): 431-436. doi: 10.19401/j.cnki.1007-3639.2023.05.002

Abstract ( 177) PDF (1118KB) ( 835 ) HTML ( 24 )

Article

PRMT7 inhibits proliferation and migration of bladder cancer cells by regulating Notch signaling pathway

WANG Xuemei, CHENG Yu, QI Jiemin

2023, 33 (5): 437-444. doi: 10.19401/j.cnki.1007-3639.2023.05.003

Abstract ( 180) PDF (1610KB) ( 765 ) HTML ( 21 )

Mechanism of circular RNA hsa_circ_0012779 expression in nasopharyngeal carcinoma and its influence on cell biological behavior

ZHANG Pingchuan, DU Mingyu, YAO Chengyun, HE Xia, YIN Li

2023, 33 (5): 445-451. doi: 10.19401/j.cnki.1007-3639.2023.05.004

Abstract ( 130) PDF (1332KB) ( 769 ) HTML ( 19 )

The feasibility and implementation of a golden beam model in Monaco treatment planning system

ZHONG Yang, YANG Yanju, ZHAO Jun, HU Weigang

2023, 33 (5): 452-459. doi: 10.19401/j.cnki.1007-3639.2023.05.005

Abstract ( 164) PDF (3386KB) ( 797 ) HTML ( 16 )

The value of combined detection of LDHA and PD-L1 in predicting the efficacy and prognosis of advanced gastric cancer patients treated with PD-1 inhibitor

ZUO Xueliang, CHEN Zhiqiang, DONG Runyu, WANG Zhixiong, CAI Juan

2023, 33 (5): 460-468. doi: 10.19401/j.cnki.1007-3639.2023.05.006

Abstract ( 157) PDF (1163KB) ( 836 ) HTML ( 22 )

Consistency analysis of PD-L1 immunohistochemistry antibodies in esophageal squamous cell carcinoma

CHEN Lijun, WANG Yichen, ZHENG Qiang, WANG Yue, JIN Yan, LI Yuan

2023, 33 (5): 469-477. doi: 10.19401/j.cnki.1007-3639.2023.05.007

Abstract ( 176) PDF (1430KB) ( 907 ) HTML ( 19 )

Analysis of risk factors of recurrence in non-muscle invasive bladder cancer patients after initial transurethral resection of bladder tumor

TANG Duocai, ZHOU Shukui, ZHANG Guiyin, LIU Lei, LIAO Hong

2023, 33 (5): 478-483. doi: 10.19401/j.cnki.1007-3639.2023.05.008

Abstract ( 120) PDF (991KB) ( 363 ) HTML ( 15 )

Characterization of immune microenvironment identifies prognostic and immunotherapy benefit for trastuzumab-based therapy

YANG Wenxiao, GUO Linwei, LING Hong, HU Xin

2023, 33 (5): 484-498. doi: 10.19401/j.cnki.1007-3639.2023.05.009

Abstract ( 152) PDF (4629KB) ( 485 ) HTML ( 16 )

Current status and influencing factors of gene screening in first-degree relatives of patients with hereditary breast-ovarian cancer syndrome

WANG Hui, WANG Xia, GAO Yi, XU Jing, YU Xiaojuan, FAN Fangqin, DING Yan, KANG Yu

2023, 33 (5): 499-505. doi: 10.19401/j.cnki.1007-3639.2023.05.010

Abstract ( 128) PDF (1160KB) ( 366 ) HTML ( 18 )

Review

Clinical dilemma and systemic treatment strategy of triple-negative breast cancer in the elderly

CHEN Junyao, ZHANG Wentao, LIU Qiao, NIE Jianyun

2023, 33 (5): 506-516. doi: 10.19401/j.cnki.1007-3639.2023.05.011

Abstract ( 168) PDF (1141KB) ( 591 ) HTML ( 17 )

Advances in fatty acid metabolism reprogramming of lung cancer

WU Jing, ZHOU Juan, SU Chunxia

2023, 33 (5): 517-526. doi: 10.19401/j.cnki.1007-3639.2023.05.012

Abstract ( 258) PDF (1202KB) ( 1633 ) HTML ( 22 )

Guideline and Concensus

Chinese expert consensus on clinical application of recombinant oncolytic adenovirus in the treatment of malignant tumors

Expert Committee on Immunotherapy of Chinese Society of Clinical Oncology , Professional Committee on Cancer Biotherapy of Shanghai Anticancer Association

2023, 33 (5): 527-548. doi: 10.19401/j.cnki.1007-3639.2023.05.013

Abstract ( 315) PDF (1296KB) ( 541 ) HTML ( 48 )

中国癌症杂志

Database Indexing

A Guide to the Core Journals of China
Chinese Science Citation Database (CSCD)
China National Knowledge Infrastructure (CNKI)
Chinese Sci-tech Paper and Citation Database (CSTPCD)
Outsanding S&T Journals of China (2020) (F5000)
World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
SCOPUS
EMBASE
DOAJ
Chemical Abstracts (CA)
Japan Science and Technology Database (JST)
The Western Pacific Region Index Medicus (WPRIM)
EBSCO
Index of Copernicus International (ICI)

Competent Authorities

　The Ministry of Education of the People’s Republic of China

Sponsored by

　Fudan University Shanghai Cancer Center

Edited by

　Editorial Board of China Oncology

Editor-in-Chief

　SHAO Zhimin

Honorary Editor-in-Chief

　TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

　Shanghai Ouyang Printing Co., Ltd.

WeChat